Treatment response to spironolactone in patients with heart failure with preserved ejection fraction: a machine learning-based analysis of two randomized controlled trials-Reference-Cited by-同舟云学术

Treatment response to spironolactone in patients with heart failure with preserved ejection fraction: a machine learning-based analysis of two randomized controlled trials

Published:2023-10 Issue: Volume:96 Page:104795
ISSN:2352-3964
Container-title:eBioMedicine
language:en
Short-container-title:eBioMedicine

Author:

Kresoja Karl-Patrik^ORCID,Unterhuber Matthias^ORCID,Wachter Rolf,Rommel Karl-Philipp,Besler Christian,Shah Sanjiv,Thiele Holger,Edelmann Frank,Lurz Philipp

Publisher

Elsevier BV

Subject

General Biochemistry, Genetics and Molecular Biology,General Medicine

Reference26 articles.

1. Phenomapping for novel classification of heart failure with preserved ejection fraction;Shah;Circulation,2015

2. Spironolactone for heart failure with preserved ejection fraction;Pitt;N Engl J Med,2014

3. Angiotensin-neprilysin inhibition in heart failure with preserved ejection fraction;Solomon;N Engl J Med,2019

4. Effect of sacubitril/valsartan vs standard medical therapies on plasma NT-proBNP concentration and submaximal exercise capacity in patients with heart failure and preserved ejection fraction: the PARALLAX randomized clinical trial;Pieske;JAMA,2021

5. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure;McDonagh;Eur Heart J,2021

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A study on the methylation patterns of DIO3 in patients with heart failure and its correlation with key clinical parameters;Heliyon;2024-09

2. Single-cell transcriptomics reveals writers of RNA modification-mediated immune microenvironment and cardiac resident Macro-MYL2 macrophages in heart failure;BMC Cardiovascular Disorders;2024-08-16

3. m6A epitranscriptomic modification of inflammation in cardiovascular disease;International Immunopharmacology;2024-06

4. Integration of body composition data in developing a Random Survival Forest model for the Prognosis of Locally Advanced Cervical Cancer patients treated with definitive Chemoradiotherapy;2024-04-25

5. Drug Therapy for Acute and Chronic Heart Failure with Preserved Ejection Fraction with Hypertension: A State-of-the-Art Review;American Journal of Cardiovascular Drugs;2024-04-04